Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-0.43%||166.86||0.7%||$1081.06m|
|LLY||Eli Lilly & Co.||0.04%||316.96||1.1%||$820.24m|
|MRK||Merck & Co., Inc.||0.42%||91.42||0.7%||$782.30m|
|BMY||Bristol-Myers Squibb Co.||-0.55%||74.15||1.0%||$614.48m|
|SIGA||SIGA Technologies, Inc.||-6.42%||23.18||0.0%||$439.36m|
|GBT||Global Blood Therapeutics, Inc.||0.08%||67.05||5.4%||$352.06m|
|ALNY||Alnylam Pharmaceuticals, Inc.||0.14%||223.45||8.2%||$270.68m|
|HZNP||Horizon Therapeutics Plc||-0.84%||61.21||5.4%||$225.68m|
|KRTX||Karuna Therapeutics, Inc.||-0.08%||261.01||0.0%||$204.69m|
NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.